Fact sheet: Polar Capital Biotechnology

Fund information

Fund name
Polar Capital Biotechnology I GBP
Fund company manager
Polar Capital
Fund type
SIB
Fund manager(s)
David Pinniger
since 31/10/2013
Fund objective
The Fund aims to preserve capital and achieve long-term capital appreciation by investing throughout the biotechnology ecosystem, across geographies and market capitalisations.
Benchmark
NASDAQ Biotechnology
Investment style
Active,Growth
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

27.51 %

1 Year rank in sector

6/30

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 236.9 m

FE Risk score

209

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    72.9%
  • Denmark
    5.6%
  • UK
    4.91%
  • Netherlands
    4.67%
  • China
    2.78%
  • Biotechnology/Medical
    84.79%
  • Pharmaceuticals
    10.5%
  • Healthcare & Medical Products
    3.49%
  • Health Care
    0.69%
  • Money Market
    0.52%
  • US Equities
    72.7%
  • Danish Equities
    5.6%
  • UK Equities
    4.9%
  • Dutch Equities
    4.7%
  • Chinese Equities
    2.8%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund5.52 %14.08 %27.51 %96.65 %0 %
Sector1.48 %8.08 %15.09 %28.3 %98.72 %
Rank within sector1 / 316 / 316 / 301 / 28 /
Quartile th1 st1 st1 st1 st th

Calendar performance

YTD-20172016201520142013
Fund24.43 %10.33 %19.48 %57.84 %0 %
Sector17.7 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector7 / 302 / 302 / 281 / 25 /
Quartile th1 st1 st1 st1 st th

Risk statistics

Alpha14.54
Beta1.22
Sharpe0.94
Volatility20.88
Tracking error9.85
Information ratio1.55
R-Squared0.8

Price movement

52 week high17.31
52 week low12.22
Current bid price0
Current offer price0
Current mid price17.01

Holdings by region

  • 72.9% USA
  • 5.6% Denmark
  • 4.91% UK
  • 4.67% Netherlands
  • 2.78% China
  • 2.53% Germany
  • 2.37% Sweden
  • 1.67% Ireland
  • 0.96% France
  • 0.52% Money Market

Holdings by sector

  • 84.79% Biotechnology/Medical
  • 10.5% Pharmaceuticals
  • 3.49% Healthcare & Medical Products
  • 0.69% Health Care
  • 0.52% Money Market

Holdings by asset type

  • 72.7% US Equities
  • 5.6% Danish Equities
  • 4.9% UK Equities
  • 4.7% Dutch Equities
  • 2.8% Chinese Equities
  • 2.5% German Equities
  • 2.4% Swedish Equities
  • 1.7% Irish Equities
  • 1% French Equities
  • 0.7% International Equities

Individual holdings

  • 8.41% CELGENE CORP
  • 7.09% BIOGEN INC
  • 5.83% VERTEX PHARMACEUTICAL
  • 5.34% REGENERON PHARMACEUTICALS INC
  • 5.05% BIOMARIN PHARMACEUTICAL
  • 4.34% TESARO INC
  • 4.18% GENMAB AS
  • 4.15% ALEXION PHARMACEUTICALS INC
  • 3.88% INCYTE CORP
  • 3.66% INTERCEPT PHARMACEUTICALS INC